Related Funds
Fund Name | Location |
Canadian Solar | Canada, Guelph, Ontario |
Coastview Capital | California, Los Angeles, United States |
Coplex | Arizona, Phoenix, United States |
Dongfang Ruijia Touzi | China, Guangdong, Shenzhen |
Drake Enterprises | Franklin, North Carolina, United States |
Edelweiss Tokio Life Insurance | India, Maharashtra, Mumbai |
Frost Venture Partners | California, San Juan Capistrano, United States |
GREE Ventures | Chiyoda, Japan |
HHIAB | - |
IQbility | Attiki, Greece, Kallithéa |
KB Global Platform Fund | Seoul, Seoul-t'ukpyolsi, South Korea |
Mihe Capital | - |
Nanshan Venture Capital | China, Guangdong, Shenzhen |
Poland Prize Program | - |
Purple Cow | Brentwood, California, United States |
Sime Darby | Kuala Lumpur, Malaysia |
Soros Fund Management | New York, New York, United States |
Times Mirror Interactive | California, Los Angeles, United States |
Tongjian Tailite | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Epitopea | 24 Oct 2024 | Cambridge, Cambridgeshire, United Kingdom | |||
Specific Biologics | 10 Oct 2023 | Ontario, California, United States | |||
Inversago Pharma | $75M | 17 Oct 2022 | Montreal, Quebec, Canada | ||
Immugenia | 06 Oct 2022 | Sherbrooke, Quebec, Canada | |||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
Specific Biologics | 16 Dec 2021 | Ontario, California, United States | |||
Inversago Pharma | $35M | 08 Sep 2020 | Quebec | ||
Bright Angel Therapeutics | 03 Dec 2019 | Old Toronto, Ontario, Canada |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Epitopea | 24 Oct 2024 | Cambridge, Cambridgeshire, United Kingdom | |||
Specific Biologics | 10 Oct 2023 | Ontario, California, United States | |||
Inversago Pharma | $75M | 17 Oct 2022 | Montreal, Quebec, Canada | ||
Immugenia | 06 Oct 2022 | Sherbrooke, Quebec, Canada | |||
Domain Therapeutics | $46M | 10 May 2022 | France, Grand Est, France | ||
Specific Biologics | 16 Dec 2021 | Ontario, California, United States | |||
Inversago Pharma | $35M | 08 Sep 2020 | Quebec | ||
Bright Angel Therapeutics | 03 Dec 2019 | Old Toronto, Ontario, Canada |